Antigoni Manousopoulou serves as the Co-founder and Chief Scientific Officer at Proteas Health, Inc., where she is at the forefront of innovative solutions aimed at combating heart disease, a leading cause of mortality worldwide. With a profound understanding of the intersection between biotechnology and clinical...
Antigoni Manousopoulou serves as the Co-founder and Chief Scientific Officer at Proteas Health, Inc., where she is at the forefront of innovative solutions aimed at combating heart disease, a leading cause of mortality worldwide. With a profound understanding of the intersection between biotechnology and clinical research, Antigoni's role encompasses a diverse range of responsibilities that are critical to the company’s mission. She spearheads fundraising initiatives by engaging with private investors and venture capitalists, ensuring that Proteas Health has the necessary resources to advance its groundbreaking research in proteomics and biomarker discovery.
In addition to her fundraising efforts, Antigoni is instrumental in fostering investor relations and securing non-dilutive funding through competitive research grants. Her strategic planning and business development acumen enable her to prioritize and oversee research operations effectively, ensuring that projects align with the company's vision of early heart disease detection and prevention. Antigoni is also dedicated to building a robust research team, overseeing the onboarding and training of personnel, and promoting a collaborative research environment that bridges academia and industry.
Her expertise in mass spectrometry, liquid chromatography-mass spectrometry (LC-MS), and high-performance liquid chromatography (HPLC) positions her as a leader in the life sciences sector, driving forward the development of innovative diagnostic tools. Antigoni's commitment to scientific writing and project management further enhances her ability to translate complex research findings into actionable insights, ultimately contributing to the fight against heart disease and improving patient outcomes. Through her leadership at Proteas Health, Antigoni Manousopoulou is not only shaping the future of cardiovascular health but also raising awareness about the silent threat of heart disease that affects millions.
